Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SHEN26
- Development stage
- Unknown
- Lead developer
- Shenzhen Kexing Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
SHEN26 (also known as ATV014) is an investigational oral small-molecule antiviral drug being developed by Shenzhen Kexing Pharmaceutical Co., Ltd. (a subsidiary of Kexing Biopharm) in collaboration with Shenzhen Antiv Pharma Co., Ltd. for the treatment of COVID-19. As an RNA-dependent RNA polymerase (RdRp) inhibitor, SHEN26 works by blocking the synthesis of viral nucleic acids, thereby inhibiting the replication of the SARS-CoV-2 virus. The drug is administered orally in capsule form and has progressed through Phase I, II, and III clinical trials, with a focus on treating mild to moderate COVID-19 in adult patients. It has been recognized as a key emergency project by China's Ministry of Science and Technology.
- Other names
- SHEN26 COVID-19 oral capsulesSHEN-26 COVID-19 oral capsulesSHEN 26 COVID-19 oral capsules
02
Targets
RdRp (Coronavirus RNA-dependent RNA polymerase)
Beyond the preview
Go deeper on SHEN26.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SHEN26.